ImmixBio Initiates GMP Manufacturing of IMX-120, a Biologic for Inflammatory Bowel Disease

ImmixBio Initiates GMP Manufacturing of IMX-120, a Biologic for Inflammatory Bowel Disease

Immix Biopharma, Inc. (NASDAQ:IMMX)

Format

JPEG

Quelle:

Immix Biopharma, Inc.

Downloads